Job Posting: Communications & Social Media Coordinator
FARA News
Blog|Feb 10 2025
Meet the Community 2: A Closer Look – Matthew LaFleur
Community
News|Feb 4 2025
Letter to the FA Community from Astellas Pharma
Industry News
Blog|Feb 3 2025
Meet The Community: Christin Haun
Community
News|Jan 29 2025
Webinar Recording: PTC Therapeutics Vatiquinone Program January 2025 Update
FARA News | Industry News
News|Jan 24 2025
Janaury 2025 – Advocacy Newsletter
Advocacy
News|Jan 23 2025
Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-In Study for Patients with Friedreich’s Ataxia
Industry News
News|Jan 21 2025
Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia
Industry News
Blog|Jan 14 2025
Living with FA, Leading in Research: FA Patient-Researchers Present at ICAR 2024
Community | Research
News|Jan 7 2025
Press Release & Community Letter: Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich’s Ataxia